Healthequity Company Profile (NASDAQ:HQY)

About Healthequity (NASDAQ:HQY)

Healthequity logoHealthEquity, Inc. provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings. Its products and services include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements and healthcare incentives. Its ecosystem primarily consists of HSA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Information Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:HQY
  • CUSIP: N/A
  • Web:
  • Market Cap: $2.7 billion
  • Outstanding Shares: 59,628,000
Average Prices:
  • 50 Day Moving Avg: $44.82
  • 200 Day Moving Avg: $43.47
  • 52 Week Range: $24.66 - $49.25
  • Trailing P/E Ratio: 102.91
  • Foreward P/E Ratio: 64.69
  • P/E Growth: 2.68
Sales & Book Value:
  • Annual Revenue: $178.37 million
  • Price / Sales: 15.14
  • Book Value: $4.40 per share
  • Price / Book: 10.29
  • EBIDTA: $54.4 million
  • Net Margins: 15.19%
  • Return on Equity: 11.08%
  • Return on Assets: 10.52%
  • Current Ratio: 17.84%
  • Quick Ratio: 17.75%
  • Average Volume: 493,449 shs.
  • Beta: 1.94
  • Short Ratio: 5.12

Frequently Asked Questions for Healthequity (NASDAQ:HQY)

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) announced its quarterly earnings data on Tuesday, March, 21st. The company reported $0.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.05 by $0.02. The business earned $46.83 million during the quarter, compared to analyst estimates of $45.55 million. Healthequity had a return on equity of 11.08% and a net margin of 15.19%. Healthequity's quarterly revenue was up 30.4% compared to the same quarter last year. During the same period last year, the company earned $0.07 earnings per share. View Healthequity's Earnings History.

When will Healthequity make its next earnings announcement?

Healthequity is scheduled to release their next quarterly earnings announcement on Monday, June, 5th 2017. View Earnings Estimates for Healthequity.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity issued an update on its FY18 earnings guidance on Tuesday, March, 21st. The company provided earnings per share guidance of $0.50-0.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.56. The company issued revenue guidance of $220-225 million, compared to the consensus revenue estimate of $222.14 million.

Where is Healthequity's stock going? Where will Healthequity's stock price be in 2017?

13 analysts have issued 1-year price targets for Healthequity's stock. Their predictions range from $33.00 to $60.00. On average, they anticipate Healthequity's share price to reach $45.80 in the next twelve months. View Analyst Ratings for Healthequity.

What are analysts saying about Healthequity stock?

Here are some recent quotes from research analysts about Healthequity stock:

  • 1. Cantor Fitzgerald analysts commented, "HSA market growth is likely to continue. Industry research indicates that there were 20 million HSAs in place at the end of 2016 with about $37 billion in assets. Given the increased popularity of high deductible health plans, the Devenir HSA report estimates that total HSA assets will increase to $52 billion in 2018. We view HQY as a cross over company as it straddles both the healthcare IT and managed care sectors. The company sells its cloud-based healthcare and spending platform to health plans and employers who offer HSA to members and employees. Generally speaking, we view HSA administration as an attractive niche within the broader benefit administration market. Direct competitors in the HSA market include Optum Bank (owned by UnitedHeatlhGroup, UNH) and Webster Financial (WBS). Benefit administration solution companies include Wageworks (WAGE) and Benefitfocus (BNFT). Consumer/employee engagement represents another niche with the broader market." (3/30/2017)
  • 2. Chardan Capital analysts commented, "Tuesday after market close HealthEquity released F4Q17 earnings with a 12% beat on adj. EBITDA driven by strong performance in their Custodial and Interchange lines of business. The company also guided to 79.5m in adj. EBITDA in F2018E, 1% above Street Consensus. We liked Management's commitment to strong financial performance and their confidence in the demand they see for HSAs in the market during their ongoing selling season. We raise our PT to $53 (from $50) based on the company's higher multiple and reiterate our Buy rating." (3/22/2017)
  • 3. FIX analysts commented, "HealthEquity, as a pure play provider of tax-advantaged health accounts and related services, is perfectly positioned to take advantage of favorable regulatory changes and the increasing shift of healthcare costs toward consumers. Among the various ACA repeal & replace proposals in DC, the one constant appears to be the push to provide ownership to consumers along with first-dollar responsibility through tax-advantaged accounts such as HSAs. A large number of employers have already embarked on this path, and the regulatory shift could significantly speed up this change and drive faster adoption. While HQY shares have moved up post-election in anticipation of favorable changes in consumer-directed health accounts, we believe there is still upside to growth and valuation. Initiate with Outperform, $58 target." (3/14/2017)
  • 4. According to Zacks Investment Research, "HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. " (3/4/2017)

Are investors shorting Healthequity?

Healthequity saw a increase in short interest during the month of April. As of April 13th, there was short interest totalling 3,736,218 shares, an increase of 10.7% from the March 31st total of 3,376,212 shares. Based on an average daily volume of 456,702 shares, the days-to-cover ratio is presently 8.2 days.

Who are some of Healthequity's key competitors?

Who owns Healthequity stock?

Healthequity's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Berkley W R Corp (14.70%), BlackRock Inc. (9.37%), Vanguard Group Inc. (6.90%), Janus Capital Management LLC (3.29%), FMR LLC (2.58%) and Wells Fargo & Company MN (2.29%). Company insiders that own Healthequity stock include Adrian T Dillon, Ashley Dreier, Darcy G Mott, Delano Ladd, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney, Michael O Leavitt and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

Who sold Healthequity stock? Who is selling Healthequity stock?

Healthequity's stock was sold by a variety of institutional investors in the last quarter, including Berkley W R Corp, Next Century Growth Investors LLC, Alliancebernstein L.P., Morgan Stanley, Janus Capital Management LLC, Victory Capital Management Inc., Wells Fargo & Company MN and OppenheimerFunds Inc.. Company insiders that have sold Healthequity stock in the last year include Ashley Dreier, Darcy G Mott, Delano Ladd, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney, Michael O Leavitt and Stephen Neeleman. View Insider Buying and Selling for Healthequity.

Who bought Healthequity stock? Who is buying Healthequity stock?

Healthequity's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Henderson Group PLC, FMR LLC, Bank of New York Mellon Corp, Vanguard Group Inc., Columbia Wanger Asset Management LLC, Kayne Anderson Rudnick Investment Management LLC and Pier Capital LLC. View Insider Buying and Selling for Healthequity.

How do I buy Healthequity stock?

Shares of Healthequity can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Healthequity stock cost?

One share of Healthequity stock can currently be purchased for approximately $45.28.

Analyst Ratings

Consensus Ratings for Healthequity (NASDAQ:HQY) (?)
Ratings Breakdown: 1 Hold Rating, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $45.80 (1.15% upside)

Analysts' Ratings History for Healthequity (NASDAQ:HQY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/30/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$50.00HighView Rating Details
3/22/2017JPMorgan Chase & Co.Boost Price TargetOverweight$44.00 -> $51.00HighView Rating Details
3/22/2017Chardan CapitalReiterated RatingBuy -> Buy$50.00 -> $53.00HighView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformMediumView Rating Details
3/14/2017FIXInitiated CoverageOutperformMediumView Rating Details
3/14/2017Wells Fargo & CoInitiated CoverageOutperformMediumView Rating Details
3/13/2017Oppenheimer Holdings Inc.Initiated CoverageOutperform$58.00MediumView Rating Details
1/23/2017KeyCorpInitiated CoverageOverweight$60.00N/AView Rating Details
9/12/2016Raymond James Financial, Inc.Boost Price TargetOutperform$32.00 -> $40.00N/AView Rating Details
9/8/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
9/8/2016Barrington ResearchBoost Price TargetOutperform$34.00 -> $38.00N/AView Rating Details
9/7/2016Robert W. BairdBoost Price TargetNeutral$31.00 -> $35.00N/AView Rating Details
6/8/2016Leerink SwannReiterated RatingOutperform$30.00 -> $33.00N/AView Rating Details
3/23/2016Avondale PartnersBoost Price TargetMarket Outperform$25.00 -> $27.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for Healthequity (NASDAQ:HQY)
Earnings by Quarter for Healthequity (NASDAQ:HQY)
Earnings History by Quarter for Healthequity (NASDAQ:HQY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/21/2017Q4 2017$0.05$0.07$45.55 million$46.83 millionViewN/AView Earnings Details
12/6/2016Q3 2017$0.09$0.10$43.29 million$43.36 millionViewN/AView Earnings Details
9/6/2016Q2$0.13$0.16$43.28 million$44.19 millionViewN/AView Earnings Details
6/7/2016Q1$0.13$0.15$42.06 million$44.01 millionViewN/AView Earnings Details
3/22/2016Q4$0.04$0.07$34.90 million$35.89 millionViewListenView Earnings Details
12/7/2015Q316$0.07$0.08$31.09 million$30.60 millionViewN/AView Earnings Details
9/8/2015Q216$0.08$0.08$29.81 million$30.50 millionViewN/AView Earnings Details
6/8/2015Q116$0.08$0.09$28.65 million$29.90 millionViewN/AView Earnings Details
3/24/2015Q415$0.02$0.04$23.50 million$24.90 millionViewN/AView Earnings Details
12/9/2014Q315$0.04$0.05$21.00 million$21.90 millionViewN/AView Earnings Details
9/9/2014Q2 15$0.05$0.07$20.32 million$20.89 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Healthequity (NASDAQ:HQY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Dividend History for Healthequity (NASDAQ:HQY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Healthequity (NASDAQ:HQY)
Insider Ownership Percentage: 29.00%
Institutional Ownership Percentage: 89.22%
Insider Trades by Quarter for Healthequity (NASDAQ:HQY)
Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)
Insider Trades by Quarter for Healthequity (NASDAQ:HQY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/1/2017Jon KesslerInsiderSell30,000$45.43$1,362,900.00View SEC Filing  
4/20/2017Darcy G MottVPSell10,000$43.44$434,400.00View SEC Filing  
4/17/2017Stephen NeelemanInsiderSell8,500$43.45$369,325.00View SEC Filing  
4/13/2017Delano LaddEVPSell1,095$43.60$47,742.00View SEC Filing  
4/4/2017Jon KesslerInsiderSell30,000$42.24$1,267,200.00View SEC Filing  
4/3/2017Jon KesslerCEOSell20,000$41.85$837,000.00View SEC Filing  
3/30/2017Adrian T. DillonDirectorBuy5,000$40.53$202,650.00View SEC Filing  
3/24/2017Jon SoldanVPSell6,250$41.95$262,187.50View SEC Filing  
3/22/2017Stephen NeelemanInsiderSell1,200$46.18$55,416.00View SEC Filing  
3/20/2017Ashley DreierVPSell5,000$45.80$229,000.00View SEC Filing  
3/20/2017Darcy G MottCFOSell10,000$45.92$459,200.00View SEC Filing  
3/20/2017Stephen NeelemanInsiderSell55,518$46.19$2,564,376.42View SEC Filing  
3/17/2017Stephen NeelemanVice ChairmanSell53,218$46.20$2,458,671.60View SEC Filing  
3/16/2017Stephen NeelemanInsiderSell40,169$45.96$1,846,167.24View SEC Filing  
2/28/2017Stephen NeelemanVice ChairmanSell1,600$44.02$70,432.00View SEC Filing  
2/27/2017Stephen NeelemanVice ChairmanSell215$44.00$9,460.00View SEC Filing  
2/21/2017Darcy G MottCFOSell10,000$42.60$426,000.00View SEC Filing  
1/20/2017Darcy G MottVPSell10,000$47.73$477,300.00View SEC Filing  
1/19/2017Frank MediciDirectorSell1,000,000$46.45$46,450,000.00View SEC Filing  
1/3/2017Frank CorvinoDirectorSell35,000$40.33$1,411,550.00View SEC Filing  
12/20/2016Darcy G MottVPSell10,000$40.12$401,200.00View SEC Filing  
12/20/2016Manu S RanaDirectorSell382,352$40.72$15,569,373.44View SEC Filing  
12/9/2016Darcy G MottVPSell30,000$40.88$1,226,400.00View SEC Filing  
11/28/2016Ashley DreierVPSell5,000$43.38$216,900.00View SEC Filing  
11/1/2016Matthew SydneyVPSell25,000$32.52$813,000.00View SEC Filing  
10/25/2016Frank MediciDirectorSell2,205,884$35.85$79,080,941.40View SEC Filing  
10/20/2016Darcy G MottVPSell10,000$35.37$353,700.00View SEC Filing  
10/13/2016Stephen NeelemanInsiderSell30,000$36.19$1,085,700.00View SEC Filing  
9/20/2016Darcy G MottCFOSell10,000$35.03$350,300.00View SEC Filing  
9/20/2016Jon KesslerCEOSell54,712$35.07$1,918,749.84View SEC Filing  
9/19/2016Jon KesslerCEOSell65,288$35.02$2,286,385.76View SEC Filing  
9/15/2016Jon KesslerInsiderSell20,000$33.46$669,200.00View SEC Filing  
9/13/2016Stephen NeelemanInsiderSell30,000$33.22$996,600.00View SEC Filing  
9/12/2016Jon KesslerInsiderSell120,117$33.10$3,975,872.70View SEC Filing  
9/12/2016Jon SoldanVPSell25,000$33.55$838,750.00View SEC Filing  
9/1/2016Ashley DreierVPSell10,000$32.28$322,800.00View SEC Filing  
8/31/2016Jon KesslerInsiderSell34,883$33.00$1,151,139.00View SEC Filing  
8/23/2016Stephen NeelemanInsiderSell9,898$30.28$299,711.44View SEC Filing  
8/22/2016Darcy G MottCFOSell10,000$29.13$291,300.00View SEC Filing  
8/18/2016Stephen NeelemanInsiderSell102$30.00$3,060.00View SEC Filing  
7/25/2016Jon KesslerInsiderSell10,000$29.62$296,200.00View SEC Filing  
7/20/2016Darcy G MottVPSell10,000$30.23$302,300.00View SEC Filing  
7/15/2016Ian SacksDirectorSell100,000$30.27$3,027,000.00View SEC Filing  
7/15/2016Jon KesslerCEOSell10,000$30.05$300,500.00View SEC Filing  
7/13/2016Stephen NeelemanVice ChairmanSell30,000$30.52$915,600.00View SEC Filing  
6/30/2016Stephen NeelemanVice ChairmanSell17,967$30.20$542,603.40View SEC Filing  
6/23/2016Jon KesslerCEOSell10,000$29.00$290,000.00View SEC Filing  
6/23/2016Michael O LeavittDirectorSell6,250$29.17$182,312.50View SEC Filing  
6/22/2016Michael O LeavittDirectorSell28,083$29.16$818,900.28View SEC Filing  
6/20/2016Darcy G MottCFOSell10,000$29.30$293,000.00View SEC Filing  
6/15/2016Jon KesslerCEOSell110,000$29.17$3,208,700.00View SEC Filing  
6/14/2016Jon KesslerCEOSell38,119$29.09$1,108,881.71View SEC Filing  
6/13/2016Jon KesslerCEOSell6,288$29.02$182,477.76View SEC Filing  
6/13/2016Stephen NeelemanVice ChairmanSell20,000$28.87$577,400.00View SEC Filing  
6/9/2016Manu S RanaDirectorSell500,000$28.30$14,150,000.00View SEC Filing  
6/8/2016Stephen NeelemanVice ChairmanSell2,033$30.12$61,233.96View SEC Filing  
5/26/2016Stephen NeelemanVice ChairmanSell19,900$25.03$498,097.00View SEC Filing  
5/25/2016Darcy G MottCFOSell10,000$25.00$250,000.00View SEC Filing  
5/13/2016Stephen NeelemanVice ChairmanSell100$25.00$2,500.00View SEC Filing  
5/11/2016Jon KesslerCEOSell52,000$25.21$1,310,920.00View SEC Filing  
4/20/2016Darcy G MottCFOSell10,000$25.52$255,200.00View SEC Filing  
4/11/2016Manu S RanaDirectorSell500,000$23.48$11,740,000.00View SEC Filing  
4/4/2016Jon KesslerCEOSell93,000$25.06$2,330,580.00View SEC Filing  
4/1/2016Darcy G MottCFOSell30,000$25.00$750,000.00View SEC Filing  
1/4/2016Stephen NeelemanVice ChairmanSell11,346$25.03$283,990.38View SEC Filing  
12/21/2015Darcy G. MottCFOSell10,000$25.70$257,000.00View SEC Filing  
12/2/2015Stephen NeelemanVice ChairmanSell37,500$32.75$1,228,125.00View SEC Filing  
12/1/2015Ashley DreierVPSell3,125$32.32$101,000.00View SEC Filing  
11/20/2015Darcy G. MottCFOSell10,000$33.64$336,400.00View SEC Filing  
11/11/2015Matthew SydneyVPSell35,000$35.00$1,225,000.00View SEC Filing  
10/28/2015Jon KesslerCEOSell20,000$32.00$640,000.00View SEC Filing  
10/20/2015Darcy G. MottCFOSell10,000$30.28$302,800.00View SEC Filing  
10/1/2015Jon KesslerCEOSell35,000$28.92$1,012,200.00View SEC Filing  
9/25/2015Frank MediciDirectorSell2,300,000$29.50$67,850,000.00View SEC Filing  
9/22/2015Frank MediciDirectorSell12,500$29.56$369,500.00View SEC Filing  
9/21/2015Darcy G. MottCFOSell10,000$30.50$305,000.00View SEC Filing  
9/17/2015Michael O LeavittDirectorSell93,703$29.82$2,794,223.46View SEC Filing  
9/16/2015Ian SacksDirectorSell50,000$29.74$1,487,000.00View SEC Filing  
9/15/2015Ian SacksDirectorSell50,000$29.99$1,499,500.00View SEC Filing  
9/14/2015Michael O LeavittDirectorSell41,297$30.57$1,262,449.29View SEC Filing  
9/11/2015Stephen NeelemanVice ChairmanSell50,000$30.06$1,503,000.00View SEC Filing  
9/3/2015Ashley DreierVPSell3,125$30.00$93,750.00View SEC Filing  
9/1/2015Jon KesslerCEOSell35,000$28.97$1,013,950.00View SEC Filing  
6/15/2015Ashley DreierVPSell3,125$28.50$89,062.50View SEC Filing  
5/11/2015Berkley Capital Investors, L.PMajor ShareholderSell2,250,000$24.86$55,935,000.00View SEC Filing  
5/11/2015Darcy G MottCFOSell120,000$24.86$2,983,200.00View SEC Filing  
5/11/2015Frank MediciDirectorSell1,125,000$24.86$27,967,500.00View SEC Filing  
5/11/2015Jon KesslerCEOSell100,000$24.86$2,486,000.00View SEC Filing  
4/28/2015Ashley DreierVPSell3,125$27.00$84,375.00View SEC Filing  
8/5/2014Darcy G MottCFOBuy2,000$14.00$28,000.00View SEC Filing  
8/5/2014Frank MediciDirectorBuy12,500$14.00$175,000.00View SEC Filing  
8/5/2014Frode JensenVPBuy3,000$14.00$42,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Healthequity (NASDAQ:HQY)
Latest Headlines for Healthequity (NASDAQ:HQY)
DateHeadline logoHealthEquity to Present at RW Baird 2017 Consumer, Technology & Services Conference - May 24 at 5:35 PM logoETFs with exposure to HealthEquity, Inc. : May 23, 2017 - May 23 at 5:21 PM logoHealthEquity Sets Date to Announce First Quarter Results - GlobeNewswire (press release) - May 16 at 10:40 PM logoHealthEquity Sets Date to Announce First Quarter Results - May 16 at 5:39 PM logoHealthequity Inc (HQY) Receives Average Recommendation of "Buy" from Brokerages - May 16 at 9:00 AM logoHealthEquity CTO Ashley Dreier Named ‘CTO of the Year’ - May 10 at 6:32 PM logo$54.86 Million in Sales Expected for Healthequity Inc (HQY) This Quarter - May 5 at 2:00 PM logoHealthequity (HQY) Earning Somewhat Favorable News Coverage, Analysis Shows - May 4 at 10:17 AM logoHealthequity Inc (HQY) Short Interest Up 10.7% in April - May 4 at 7:12 AM logoHealthEquity to Present at BAML Healthcare Conference - GlobeNewswire (press release) - May 3 at 4:33 PM logoHealthEquity to Present at BAML Healthcare Conference - May 3 at 4:33 PM logo Brokerages Expect Healthequity Inc (HQY) Will Announce Earnings of $0.16 Per Share - May 3 at 4:08 PM logoJon Kessler Sells 30,000 Shares of Healthequity Inc (HQY) Stock - May 3 at 12:40 AM logoHealthequity (HQY) Receives Daily Coverage Optimism Rating of 0.06 - April 30 at 3:05 PM logoHealthequity (HQY) Earning Somewhat Positive Press Coverage, Study Shows - April 27 at 9:58 PM logoDarcy G. Mott Sells 10,000 Shares of Healthequity Inc (HQY) Stock - April 24 at 11:02 PM logoHealthequity (HQY) Receives News Impact Score of -0.22 - April 24 at 10:52 AM logoHealthequity (HQY) Receives Daily News Sentiment Rating of 0.16 - April 21 at 4:00 PM logoHealthequity Inc (HQY) Given Average Recommendation of "Buy" by Brokerages - April 21 at 9:47 AM logoHealthequity Inc (HQY) Insider Stephen Neeleman Sells 8,500 Shares - April 19 at 10:44 PM logoETFs with exposure to HealthEquity, Inc. : April 19, 2017 - April 19 at 5:37 PM logoHealthequity (HQY) Receiving Favorable Media Coverage, Study Shows - April 18 at 6:48 PM logoHealthequity (HQY) Getting Somewhat Positive Media Coverage, Study Finds - April 15 at 11:45 AM logoDelano Ladd Sells 1,095 Shares of Healthequity Inc (HQY) Stock - April 14 at 7:41 PM logoZacks: Analysts Anticipate Healthequity Inc (HQY) Will Post Quarterly Sales of $54.86 Million - April 14 at 1:42 PM logoZacks: Analysts Expect Healthequity Inc (HQY) Will Announce Earnings of $0.16 Per Share - April 12 at 12:58 PM logoHealthEquity, Inc. breached its 50 day moving average in a Bullish Manner : HQY-US : April 11, 2017 - April 11 at 12:03 PM logoMassive Consumer Staple Trade Highlights Insider Buying: Campbell Soup, Apollo Global, G-III Apparel and More - April 9 at 10:42 AM logoHealthEquity, Inc. :HQY-US: Earnings Analysis: Q4, 2017 By the Numbers : April 4, 2017 - April 7 at 10:17 AM logoETFs with exposure to HealthEquity, Inc. : April 5, 2017 - April 7 at 10:17 AM logoHealthequity Inc (HQY) CEO Jon Kessler Sells 20,000 Shares - April 5 at 10:48 PM logoHealthequity Inc (HQY) Insider Sells $1,267,200.00 in Stock - April 5 at 8:03 PM logoHealthequity Inc (HQY) Coverage Initiated by Analysts at Cantor Fitzgerald - April 5 at 9:01 AM logoAdrian T. Dillon Acquires 5,000 Shares of Healthequity Inc (HQY) Stock - April 3 at 10:59 PM logoHEALTHEQUITY INC Files SEC form 8-K, Change in Directors or Principal Officers - March 31 at 5:47 PM logoHealthequity Inc (HQY) Research Coverage Started at Cantor Fitzgerald - March 30 at 7:36 PM logoHEALTHEQUITY INC Files SEC form 10-K, Annual Report - March 30 at 6:06 PM logoHealthequity Inc (HQY) VP Jon Soldan Sells 6,250 Shares - March 29 at 9:34 AM logoHealthEquity Announces New Sales and Marketing Leadership - GlobeNewswire (press release) - March 28 at 10:25 PM logoHealthEquity Announces New Sales and Marketing Leadership - March 28 at 11:24 AM logoHealthequity Inc (HQY) Given Consensus Recommendation of "Buy" by Brokerages - March 27 at 1:08 PM logoStephen Neeleman Sells 1,200 Shares of Healthequity Inc (HQY) Stock - March 23 at 10:35 PM logoHealthEquity's (HQY) CEO Jon Kessler on Q4 2017 Results ... - Seeking Alpha - March 22 at 10:55 PM logoInsider Selling: Healthequity Inc (HQY) VP Sells 5,000 Shares of Stock - March 22 at 10:28 PM logoHealthequity Inc (HQY) CFO Sells $459,200.00 in Stock - March 22 at 10:26 PM logoHealthequity Inc (HQY) Price Target Raised to $51.00 at JPMorgan Chase & Co. - March 22 at 2:26 PM logoStephen Neeleman Sells 53,218 Shares of Healthequity Inc (HQY) Stock - March 22 at 11:40 AM logoHealthEquity Inc. (HQY) Is Rising After Q4 Earnings Surpassed Expectations - March 22 at 10:00 AM logoEdited Transcript of HQY earnings conference call or presentation 21-Mar-17 9:00pm GMT - March 22 at 10:00 AM logoHealthequity Inc (HQY) Price Target Increased to $53.00 by Analysts at Chardan Capital - March 22 at 9:52 AM



Healthequity (HQY) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff